Asupardo, Reahme M.

HRN: 21-37-93  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/02/2022
CEFUROXIME 750MG (VIAL)
06/02/2022
06/08/2022
IV
750mg
Q8hours
Prophylaxis For CS

 Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: Non-compliant To Guidelines